Peripheral signals mediate the beneficial effects of gastric surgery in obesity

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Barja Fernández, Silvia ^a,b,c   Folgueira, Cintia ^a,b,c   Castelao, Cecilia ^a,c   Leis, Rosaura ^b   Casanueva, Felipe F ^b,c   Seoane, Luisa M ^a,c  

^a Santiago University Clinical Hospital   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANTIOBESITY AGENT; CHOLECYSTOKININ; GASTRIN; GHRELIN; GLUCAGON LIKE PEPTIDE 1; LEPTIN; NESFATIN 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

BARIATRIC SURGERY; CENTRAL NERVOUS SYSTEM; ENERGY BALANCE; FOOD INTAKE; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FLORA; OBESITY; REVIEW; STOMACH SURGERY;

EID: 84928790635     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/560938     Document Type: Review

References (163)

1. WHO, The SuRF Report 2, 2005.
2. European-Commission, Strategy for Europe and Nutrition, Overweight and Obesity Related Health Issues-Implementation Progress Report 2010, European-Commission, 2010.
3. Y. Wang and M. A. Beydoun, "The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and metaregression analysis, " Epidemiologic Reviews, vol. 29, no. 1, pp. 6-28, 2007.
4. R. J. Rodgers, M. H. Tschp, and J. P. H. Wilding, "Anti-obesity drugs: past, present and future, " DiseaseModels &Mechanisms, vol. 5, no. 5, pp. 621-626, 2012.
5. C. W. Breaux, "Obesity surgery in children, " Obesity Surgery, vol. 5, no. 3, pp. 279-284, 1995.
6. WHO, Obesity and Overweight-Fact Sheet, WHO, 2006.
7. J. A. Rivera, S. Barquera, F. Campirano, I. Campos, M. Safdie, and V. Tovar, "Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity, " Public Health Nutrition, vol. 5, no. 1 A, pp. 113-122, 2002.
8. B. M. Popkin, L. S. Adair, and S. W. Ng, "Global nutrition transition and the pandemic of obesity in developing countries, " Nutrition Reviews, vol. 70, no. 1, pp. 3-21, 2012.
9. M. Carotenuto, N. Santoro, A. Grandone et al. , "The insulin gene variable number of tandem repeats (INS VNTR) genotype and sleep disordered breathing in childhood obesity, " Journal of Endocrinological Investigation, vol. 32, no. 9, pp. 752-755, 2009.
10. NHLBI, "Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report, " Tech. Rep. 98-4083, 1998.
11. A. H. Mokdad, E. S. Ford, B. A. Bowman et al. , "Diabetes trends in the U. S. : 1990-1998, " Diabetes Care, vol. 23, no. 9, pp. 1278-1283, 2000.
12. K. O'Dea, "Overview of the thrifty genotype hypothesis, " Asia Pacific Journal of Clinical Nutrition, vol. 4, pp. 339-340, 1995.
13. C. Diguez, M. J. Vazquez, A. Romero, M. Lpez, and R. Nogueiras, "Hypothalamic control of lipid metabolism: focus on leptin, ghrelin and melanocortins, " Neuroendocrinology, vol. 94, no. 1, pp. 1-11, 2011.
14. R. Lage, C. Diguez, A. Vidal-Puig, and M. Lpez, "AMPK: a metabolic gauge regulating whole-body energy homeostasis, " Trends inMolecularMedicine, vol. 14, no. 12, pp. 539-549, 2008.
15. S. J. Guyenet and M. W. Schwartz, "Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity, "The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 3, pp. 745-755, 2012.
16. O. Al-Massadi, A. B. Crujeiras, R. C. Gonzlez et al. , "Age, sex, and lactating status regulate ghrelin secretion and GOAT mRNA levels from isolated rat stomach, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 299, no. 3, pp. E341-E350, 2010.
17. P. E. Sawchenko, "Central connections of the sensory and motor nuclei of the vagus nerve, " Journal of the Autonomic Nervous System, vol. 9, no. 1, pp. 13-26, 1983.
18. S. J. Konturek, T. Brzozowski, P. C. Konturek et al. , "Braingut and appetite regulating hormones in the control of gastric secretion and mucosal protection, " Journal of Physiology and Pharmacology, vol. 59, no. 2, pp. 7-31, 2008.
19. H.-R. Berthoud, "The vagus nerve, food intake and obesity, " Regulatory Peptides, vol. 149, no. 1-3, pp. 15-25, 2008.
20. M. T. Neary and R. L. Batterham, "Gut hormones: implications for the treatment of obesity, " Pharmacology &Therapeutics, vol. 124, no. 1, pp. 44-56, 2009.
21. C. Folgueira, L. M. Seoane, and F. F. Casanueva, "The brainstomach connection, " Frontiers of Hormone Research, vol. 42, pp. 83-92, 2014.
22. D. Cota, G. Marsicano, B. Lutz et al. , "Endogenous cannabinoid system as a modulator of food intake, " International Journal of Obesity and Related Metabolic Disorders, vol. 27, no. 3, pp. 289-301, 2003.
23. M. R. Pazos, R. M. Toln, C. Benito et al. , "Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa, "The Journal of Histochemistry and Cytochemistry, vol. 56, no. 5, pp. 511-516, 2008.
24. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, "Ghrelin is a growth-hormone-releasing acylated peptide fromstomach, " Nature, vol. 402, no. 6762, pp. 656-660, 1999.
25. Y. Date, M. Kojima, H. Hosoda et al. , "Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans, " Endocrinology, vol. 141, no. 11, pp. 4255-4261, 2000.
26. O. Al Massadi, M. H. Tschp, and J. Tong, "Ghrelin acylation and metabolic control, " Peptides, vol. 32, no. 11, pp. 2301-2308, 2011.
27. H. Ariyasu, K. Takaya, T. Tagami et al. , "Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans, " The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 10, pp. 4753-4758, 2001.
28. A. Inui, A. Asakawa, C. Y. Bowers et al. , "Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ, " The FASEB Journal, vol. 18, no. 3, pp. 439-456, 2004.
29. L. M. Seoane, O. Al-Massadi, F. Barreiro, C. Dieguez, and F. F. Casanueva, "Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system, " Journal of Endocrinological Investigation, vol. 30, no. 9, pp. RC22-RC25, 2007.
30. A. M. Wren and S. R. Bloom, "Gut hormones and appetite control, " Gastroenterology, vol. 132, no. 6, pp. 2116-2130, 2007.
31. L. M. Seoane, O. Al-Massadi, J. E. Caminos, S. A. Tovar, C. Dieguez, and F. F. Casanueva, "Sensory stimuli directly acting at the central nervous system regulate gastric ghrelin secretion. An ex vivo organ culture study, " Endocrinology, vol. 148, no. 8, pp. 3998-4006, 2007.
32. M. Tschp, C. Weyer, P. A. Tataranni, V. Devanarayan, E. Ravussin, and M. L. Heiman, "Circulating ghrelin levels are decreased in human obesity, " Diabetes, vol. 50, no. 4, pp. 707-709, 2001.
33. T. K. Hansen, R. Dall, H. Hosoda et al. , "Weight loss increases circulating levels of ghrelin in human obesity, " Clinical Endocrinology, vol. 56, no. 2, pp. 203-206, 2002.
34. H. R. Kissileff, F. X. Pi-Sunyer, J. Thornton, andG. P. Smith, "Cterminal octapeptide of cholecystokinin decreases food intake in man, "The American Journal of Clinical Nutrition, vol. 34, no. 2, pp. 154-160, 1981.
35. R. C. Ritter, M. Covasa, and C. A. Matson, "Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight, " Neuropeptides, vol. 33, no. 5, pp. 387-399, 1999.
36. F. A. Duca andM. Covasa, "Current and emerging concepts on the role of peripheral signals in the control of food intake and development of obesity, " The British Journal of Nutrition, vol. 108, no. 5, pp. 778-793, 2012.
37. K. Zwirska-Korczala, S. J. Konturek, M. Sodowski et al. , "Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome, " Journal of Physiology and Pharmacology, vol. 58, no. 1, pp. 13-35, 2007.
38. J.-F. Gautier, S.-P. Choukem, and J. Girard, "Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes, " Diabetes & Metabolism, vol. 34, supplement 2, pp. S65-S72, 2008.
39. B. Kreymann, G. Williams, M. A. Ghatei, and S. R. Bloom, "Glucagon-like peptide-1 7-36: a physiological incretin in man, " The Lancet, vol. 2, no. 8571, pp. 1300-1304, 1987.
40. R. M. Elliott, L. M. Morgan, J. A. Tredger, S. Deacon, J. Wright, and V. Marks, "Glucagon-like peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns, " The Journal of Endocrinology, vol. 138, no. 1, pp. 159-166, 1993.
41. E. Adamska, L. Ostrowska, M. Goska, and A. Kretwski, "The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes, " Przeglad Gastroenterologiczny, vol. 9, no. 2, pp. 69-76, 2014.
42. J. J. Holst, "The physiology of glucagon-like peptide 1, " Physiological Reviews, vol. 87, no. 4, pp. 1409-1439, 2007.
43. L. L. Baggio and D. J. Drucker, "Biology of Incretins: GLP-1 and GIP, " Gastroenterology, vol. 132, no. 6, pp. 2131-2157, 2007.
44. S. E. Kanoski, S. M. Fortin, M. Arnold, H. J. Grill, and M. R. Hayes, "Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4, " Endocrinology, vol. 152, no. 8, pp. 3103-3112, 2011.
45. D. A. D'Alessio, D. A. Sandoval, and R. J. Seeley, "New ways in which GLP-1 can regulate glucose homeostasis, " The Journal of Clinical Investigation, vol. 115, no. 12, pp. 3406-3408, 2005.
46. F. Rodriguez de Fonseca, M. Navarro, E. Alvarez et al. , "Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats, " Metabolism: Clinical and Experimental, vol. 49, no. 6, pp. 709-717, 2000.
47. C. R. Abbott, M. Monteiro, C. J. Small et al. , "The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway, " Brain Research, vol. 1044, no. 1, pp. 127-131, 2005.
48. P. K. Chelikani, A. C. Haver, and R. D. Reidelberger, "Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 288, no. 6, pp. R1695-R1706, 2005.
49. E. B. Rttimann, M. Arnold, J. J. Hillebrand, N. Geary, and W. Langhans, "Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via differentmechanisms, " Endocrinology, vol. 150, no. 3, pp. 1174-1181, 2009.
50. K. A. Scott and T. H. Moran, "The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 293, no. 3, pp. R983-R987, 2007.
51. E. Nslund, M. Gutniak, S. Skogar, S. Rssner, and P. M. Hellstr m, "Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men, " The American Journal of Clinical Nutrition, vol. 68, no. 3, pp. 525-530, 1998.
52. J. P. Gutzwiller, J. Drewe, B. Gke et al. , "Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 276, no. 5, pp. R1541-R1544, 1999.
53. A. Flint, A. Raben, A. Astrup, and J. J. Holst, "Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans, "The Journal of Clinical Investigation, vol. 101, no. 3, pp. 515-520, 1998.
54. A. Flint, A. Raben, A. K. Ersbl, J. J. Holst, and A. Astrup, "The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity, " International Journal of Obesity and Related Metabolic Disorders, vol. 25, no. 6, pp. 781-792, 2001.
55. C. Verdich, A. Flint, J.-P. Gutzwiller et al. , "A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans, "The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 9, pp. 4382-4389, 2001.
56. N. Fukase, M. Igarashi, H. Takahashi et al. , "Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients, " Diabetic Medicine, vol. 10, no. 1, pp. 44-49, 1993.
57. T. Vilsbl, T. Krarup, J. Sonne et al. , "Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus, "The Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 6, pp. 2706-2713, 2003.
58. C. Verdich, S. Toubro, B. Buemann, J. Lysgard Madsen, J. Juul Holst, and A. Astrup, "The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction, " International Journal of Obesity and RelatedMetabolic Disorders, vol. 25, no. 8, pp. 1206-1214, 2001.
59. L. R. Ranganath, J. M. Beety, L. M. Morgan, J. W. Wright, R. Howland, andV. Marks, "AttenuatedGLP-1 secretion in obesity: cause or consequence" Gut, vol. 38, no. 6, pp. 916-919, 1996.
60. P. J. Tomasik, K. Sztefko, and A. Malek, "GLP-1 as a satiety factor in children with eating disorders, " Hormone and Metabolic Research, vol. 34, no. 2, pp. 77-80, 2002.
61. R. Lugari, A. Dei Cas, D. Ugolotti et al. , "Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion, " Hormone and Metabolic Research, vol. 36, no. 2, pp. 111-115, 2004.
62. M.-B. Toft-Nielsen, M. B. Damholt, S. Madsbad et al. , "Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients, " The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 8, pp. 3717-3723, 2001.
63. A. A. Vaag, J. J. Holst, A. Vund, and H. Beck-Nielsen, "Gut incretin hormones in identical twins discordant for noninsulin-dependent diabetes mellitus (NIDDM)-evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion inNIDDMtwins, " European Journal of Endocrinology, vol. 135, no. 4, pp. 425-432, 1996.
64. E. Muscelli, A. Mari, A. Casolaro et al. , "Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients, " Diabetes, vol. 57, no. 5, pp. 1340-1348, 2008.
65. I. S. Oh, H. Shimizu, T. Satoh et al. , "Identification of nesfatin-1 as a satiety molecule in the hypothalamus, " Nature, vol. 443, no. 7112, pp. 709-712, 2006.
66. M. Goebel-Stengel and L. Wang, "Central and peripheral expression and distribution of NUCB2/nesfatin-1, " Current Pharmaceutical Design, vol. 19, no. 39, pp. 6935-6940, 2013.
67. A. Stengel, M. Mori, and Y. Tach, "The role of nesfatin-1 in the regulation of food intake and body weight: Recent developments and future endeavors, " Obesity Reviews, vol. 14, no. 11, pp. 859-870, 2013.
68. A. Stengel, M. Goebel, and Y. Tach, "Nesfatin-1: a novel inhibitory regulator of food intake and body weight, " Obesity Reviews, vol. 12, no. 4, pp. 261-271, 2011.
69. D. Garc-Galiano and M. Tena-Sempere, "Emerging roles of NUCB2/Nesfatin-1 in the metabolic control of reproduction, " Current Pharmaceutical Design, vol. 19, no. 39, pp. 6966-6972, 2013.
70. B. K. Tan, M. Hallschmid, W. Kern, H. Lehnert, and H. S. Randeva, "Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment, " The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 4, pp. E669-E673, 2011.
71. M. Ramanjaneya, J. Chen, J. E. Brown et al. , "Identification of nesfatin-1 in human and murine adipose tissue: a novel depotspecific adipokine with increased levels in obesity, " Endocrinology, vol. 151, no. 7, pp. 3169-3180, 2010.
72. J. H. Walsh, "Role of gastrin as a trophic hormone, " Digestion, vol. 47, supplement 1, pp. 11-52, 1990.
73. J. F. Rehfeld and F. Stadil, "The effect of gastrin on basal-and glucose-stimulated insulin secretion in man, " The Journal of Clinical Investigation, vol. 52, no. 6, pp. 1415-1426, 1973.
74. M. Adami, P. Frati, S. Bertini et al. , "Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach, " British Journal of Pharmacology, vol. 135, no. 7, pp. 1598-1606, 2002.
75. G. Coruzzi, M. Adami, G. Coppelli, P. Frati, and G. Soldani, "Inhibitory effect of the cannabinoid receptor agonist WIN 55, 212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat, " Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 360, no. 6, pp. 715-718, 1999.
76. M. Adami, R. Zamfirova, E. Sotirov et al. , "Gastric antisecretory effects of synthetic cannabinoids after central or peripheral administration in the rat, " Brain Research Bulletin, vol. 64, no. 4, pp. 357-361, 2004.
77. R. S. Ahima and J. S. Flier, "Leptin, " Annual Review of Physiology, vol. 62, pp. 413-437, 2000.
78. L. M. Seoane, M. Lpez, S. Tovar, F. F. Casanueva, R. Señar, and C. Diguez, "Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus, " Endocrinology, vol. 144, no. 2, pp. 544-551, 2003.
79. A. T. Turer and P. E. Scherer, "Adiponectin: mechanistic insights and clinical implications, " Diabetologia, vol. 55, no. 9, pp. 2319-2326, 2012.
80. J. Fruebis, T.-S. Tsao, S. Javorschi et al. , "Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice, " Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 4, pp. 2005-2010, 2001.
81. K. Kishida, T. Funahashi, and I. Shimomura, "Adiponectin as a routine clinical biomarker, " Best Practice & Research: Clinical Endocrinology and Metabolism, vol. 28, no. 1, pp. 119-130, 2014.
82. M. Blher, "Adipokines-removing road blocks to obesity and diabetes therapy, " Molecular Metabolism, vol. 3, no. 3, pp. 230-240, 2014.
83. N. M. Delzenne and P. D. Cani, "Interaction between obesity and the gut microbiota: relevance in nutrition, " Annual Review of Nutrition, vol. 31, pp. 15-31, 2011.
84. F. Bckhed, H. Ding, T. Wang et al. , "The gut microbiota as an environmental factor that regulates fat storage, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 44, pp. 15718-15723, 2004.
85. P. D. Cani, J. Amar, M. A. Iglesias et al. , "Metabolic endotoxemia initiates obesity and insulin resistance, " Diabetes, vol. 56, no. 7, pp. 1761-1772, 2007.
86. P. D. Cani, R. Bibiloni, C. Knauf et al. , "Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice, " Diabetes, vol. 57, no. 6, pp. 1470-1481, 2008.
87. P. D. Cani, S. Possemiers, T. van de Wiele et al. , "Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, " Gut, vol. 58, no. 8, pp. 1091-1103, 2009.
88. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, "An obesity-associated gut microbiome with increased capacity for energy harvest, " Nature, vol. 444, no. 7122, pp. 1027-1031, 2006.
89. P. J. Turnbaugh, F. Bckhed, L. Fulton, and J. I. Gordon, "Dietinduced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome, " Cell Host & Microbe, vol. 3, no. 4, pp. 213-223, 2008.
90. E. F. Murphy, P. D. Cotter, S. Healy et al. , "Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models, " Gut, vol. 59, no. 12, pp. 1635-1642, 2010.
91. L. Geurts, V. Lazarevic, M. Derrien et al. , "Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: Impact on apelin regulation in adipose tissue, " Frontiers in Microbiology, vol. 2, article 149, 2011.
92. R. E. Ley, D. A. Peterson, and J. I. Gordon, "Ecological and evolutionary forces shaping microbial diversity in the human intestine, " Cell, vol. 124, no. 4, pp. 837-848, 2006.
93. J.-P. Furet, L.-C. Kong, J. Tap et al. , "Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers, " Diabetes, vol. 59, no. 12, pp. 3049-3057, 2010.
94. G. G. Muccioli, D. Naslain, F. Bckhed et al. , "The endocannabinoid system links gut microbiota to adipogenesis, " Molecular Systems Biology, vol. 6, article 392, 2010.
95. R. F. Kushner, "Weight loss strategies for treatment of obesity, " Progress in Cardiovascular Diseases, vol. 56, no. 4, pp. 465-472, 2014.
96. M. L. Dansinger, J. A. Gleason, J. L. Griffith, H. P. Selker, and E. J. Schaefer, "Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for weight loss and heart disease risk reduction: a randomized trial, " Journal of the American Medical Association, vol. 293, no. 1, pp. 43-53, 2005.
97. E. S. Leblanc, E. O'Connor, E. P. Whitlock, C. D. Patnode, and T. Kapka, "Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U. S. Preventive Services Task Force, " Annals of Internal Medicine, vol. 155, no. 7, pp. 434-447, 2011.
98. M. Blher, "Clinical relevance of adipokines, " Diabetes & Metabolism Journal, vol. 36, no. 5, pp. 317-327, 2012.
99. S. Z. Yanovski and J. A. Yanovski, "Long-term drug treatment for obesity: a systematic and clinical review, " Journal of the American Medical Association, vol. 311, no. 1, pp. 74-86, 2014.
100. T. D. Mller, L. M. Sullivan, K. Habegger et al. , "Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21, " Journal of Peptide Science, vol. 18, no. 6, pp. 383-393, 2012.
101. J. T. Heiker, N. Klting, P. Kovacs et al. , "Vaspin inhibits kallikrein 7 by serpin mechanism, " Cellular and Molecular Life Sciences, vol. 70, no. 14, pp. 2569-2583, 2013.
102. C. Cant and J. Auwerx, "PGC-1, SIRT1 and AMPK, an energy sensing network that controls energy expenditure, " Current Opinion in Lipidology, vol. 20, no. 2, pp. 98-105, 2009.
103. L. L. Senin, O. Al-Massadi, C. Folgueira et al. , "The gastric CB1 receptormodulates ghrelin production through themTOR pathway to regulate food intake, " PLoS ONE, vol. 8, no. 11, e80339, 2013.
104. A. Caixas, L. Albert, I. Capel, and M. Rigla, "Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date, " Drug Design, Development andTherapy, vol. 8, pp. 1419-1427, 2014.
105. S. Barja-Fenndez, R. Leis, F. F. Casanueva, and L. M. Seoane, "Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss, " Drug Design, Development andTherapy, no. 8, pp. 2391-2400, 2014.
106. "Gastrointestinal surgery for severe obesity: National Institutes of Health consensus development conference statement, " The American Journal of Clinical Nutrition, vol. 55, no. 2, supplement, pp. 615S-619S, 1992.
107. A. D. Miras and C. W. le Roux, "Mechanisms underlying weight loss after bariatric surgery, " Nature Reviews. Gastroenterology & Hepatology, vol. 10, no. 10, pp. 575-584, 2013.
108. V. Ionut, M. Burch, A. Youdim, and R. N. Bergman, "Gastrointestinal hormones and bariatric surgery-induced weight loss, " Obesity, vol. 21, no. 6, pp. 1093-1103, 2013.
109. J. B. Dixon, C. W. le Roux, F. Rubino, and P. Zimmet, "Bariatric surgery for type 2 diabetes, " The Lancet, vol. 379, no. 9833, pp. 2300-2311, 2012.
110. L. M. S. Carlsson, M. Peltonen, S. Ahlin et al. , "Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects, " The New England Journal of Medicine, vol. 367, no. 8, pp. 695-704, 2012.
111. S. Scholtz, A. D. Miras, N. Chhina et al. , "Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding, " Gut, vol. 63, no. 6, pp. 891-902, 2014.
112. I. Melnikova and D. Wages, "Anti-obesity therapies, " Nature Reviews Drug Discovery, vol. 5, no. 5, pp. 369-370, 2006.
113. P. Topart, G. Becouarn, A. Sall, and P. Ritz, "Biliopancreatic diversion requires multiple vitamin and micronutrient adjustments within 2 years of surgery, " Surgery forObesity andRelated Diseases, vol. 10, no. 5, pp. 936-941, 2014.
114. H. P. Santry, D. L. Gillen, and D. S. Lauderdale, "Trends in bariatric surgical procedures, " The Journal of the American Medical Association, vol. 294, no. 15, pp. 1909-1917, 2005.
115. L. Sjstrm, M. Peltonen, P. Jacobson et al. , "Bariatric surgery and long-term cardiovascular events, " Journal of the American Medical Association, vol. 307, no. 1, pp. 56-65, 2012.
116. M. A. Stefater, H. E. Wilson-Prez, A. P. Chambers, D. A. Sandoval, and R. J. Seeley, "All bariatric surgeries are not created equal: insights from mechanistic comparisons, " Endocrine Reviews, vol. 33, no. 4, pp. 595-622, 2012.
117. M. Osto, K. Abegg, M. Bueter, C. W. le Roux, P. D. Cani, and T. A. Lutz, "Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine, " Physiology & Behavior, vol. 119, pp. 92-96, 2013.
118. M. Gass, C. Beglinger, and R. Peterli, "Metabolic surgery-principles and current concepts, " Langenbeck's Archives of Surgery, vol. 396, no. 7, pp. 949-972, 2011.
119. I. J. Hatoum, D. M. Greenawalt, C. Cotsapas, M. L. Reitman, M. J. Daly, and L. M. Kaplan, "Heritability of the weight loss response to gastric bypass surgery, "The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 10, pp. E1630-E1633, 2011.
120. T. Auguet, X. Terra, M. Hernndez et al. , "Clinical and adipocytokine changes after bariatric surgery in morbidly obese women, " Obesity, vol. 22, no. 1, pp. 188-194, 2014.
121. R. Peterli, B. Wlnerhanssen, T. Peters et al. , "Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial, " Annals of Surgery, vol. 250, no. 2, pp. 234-241, 2009.
122. M. Nannipieri, S. Baldi, A. Mari et al. , "Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones, "The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 11, pp. 4391-4399, 2013.
123. X. Terra, T. Auguet, E. Guiu-Jurado et al. , "Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy, " Obesity Surgery, vol. 23, no. 11, pp. 1790-1798, 2013.
124. A. Yousseif, J. Emmanuel, E. Karra et al. , "Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans, " Obesity Surgery, vol. 24, no. 2, pp. 241-252, 2014.
125. W.-J. Lee, C.-Y. Chen, K. Chong, Y.-C. Lee, S.-C. Chen, and S.-D. Lee, "Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy, " Surgery for Obesity and Related Diseases, vol. 7, no. 6, pp. 683-690, 2011.
126. C. Holdstock, B. E. Engstrm, M. Ohrvall, L. Lind, M. Sundbom, and F. A. Karlsson, "Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans, " Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 7, pp. 3177-3183, 2003.
127. A. F. R. Dixon, J. B. Dixon, and P. E. O'Brien, "Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study, "The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 2, pp. 813-819, 2005.
128. R. Stoeckli, R. Clianda, I. Langer, and U. Keller, "Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass, " Obesity Research, vol. 12, no. 2, pp. 346-350, 2004.
129. A. C. Krieger, H. Youn, F. Modersitzki et al. , "Effects of laparoscopic adjustable gastric banding on sleep and metabolism: a 12-month follow-up study, " International Journal of General Medicine, vol. 5, pp. 975-981, 2012.
130. J. Korner, W. Inabnet, G. Febres et al. , "Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass, " International Journal of Obesity, vol. 33, no. 7, pp. 786-795, 2009.
131. F. Rodieux, V. Giusti, D. A. D'Alessio, M. Suter, and L. Tappy, "Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release, " Obesity (Silver Spring), vol. 16, no. 2, pp. 298-305, 2008.
132. E. Dimitriadis, M. Daskalakis, M. Kampa, A. Peppe, J. A. Papadakis, and J. Melissas, "Alterations in gut hormones after laparoscopic sleeve gastrectomy: a prospective clinical and laboratory investigational study, " Annals of Surgery, vol. 257, no. 4, pp. 647-654, 2013.
133. M. Tsoli, A. Chronaiou, I. Kehagias, F. Kalfarentzos, and T. K. Alexandrides, "Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study, " Surgery for Obesity and Related Diseases, vol. 9, no. 5, pp. 667-677, 2013.
134. T. E. Sweeney and J. M. Morton, "Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota A summary of the literature, " Best Practice & Research. Clinical Gastroenterology, vol. 28, pp. 727-740, 2014.
135. L. Ockander, J. L. Hedenbro, J. F. Rehfeld, and K. Sjlund, "Jejunoileal bypass changes the duodenal cholecystokinin and somatostatin cell density, " Obesity Surgery, vol. 13, no. 4, pp. 584-590, 2003.
136. C. B. Chan, A. M. J. Buchan, K. A. Green, and R. A. Pederson, "The effect of jejunoileal bypass (JIB) in the obese Zucker rat on a sub-group of enteroendocrine cells, " International Journal of Obesity, vol. 11, no. 3, pp. 285-293, 1987.
137. A. M. J. Buchan, R. A. Pederson, I. Koop, R. H. Gourlay, andI. G. M. Cleator, "Morphological and functional alterations to a subgroup of regulatory peptides in human pancreas and intestine after jejuno-ileal bypass, " International Journal of Obesity, vol. 17, no. 2, pp. 109-113, 1993.
138. E. Nslund, P. Grybck, P. M. Hellstrm et al. , "Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass formassive obesity, " International Journal of Obesity, vol. 21, no. 5, pp. 387-392, 1997.
139. J. M. Kellum, J. F. Kuemmerle, T. M. O'Dorisio et al. , "Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty, " Annals of Surgery, vol. 211, no. 6, pp. 763-770, 1990.
140. S. H. Jacobsen, S. C. Olesen, C. Dirksen et al. , "Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in nondiabetic subjects, " Obesity Surgery, vol. 22, no. 7, pp. 1084-1096, 2012.
141. R. Peterli, R. E. Steinert, B. Woelnerhanssen et al. , "Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial, " Obesity Surgery, vol. 22, no. 5, pp. 740-748, 2012.
142. C. P. de Carvalho, D. M. Marin, A. L. de Souza et al. , "GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism, " Obesity Surgery, vol. 19, no. 3, pp. 313-320, 2009.
143. S. Evans, Z. Pamuklar, J. Rosko et al. , "Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction, " Surgical Endoscopy and Other Interventional Techniques, vol. 26, no. 4, pp. 1086-1094, 2012.
144. W.-J. Lee, C.-Y. Chen, K.-H. Ser et al. , "Differential influences of gastric bypass and sleeve gastrectomy on plasma nesfatin-1 and obestatin levels in patients with type 2 diabetes mellitus, " Current Pharmaceutical Design, vol. 19, no. 32, pp. 5830-5835, 2013.
145. E. Grong, I. B. Arbo, O. K. Thu, E. Kuhry, B. Kulseng, and R. Marvik, "The effect of duodenojejunostomy and sleeve gastrectomy on type 2 diabetes mellitus and gastrin secretion in Goto-Kakizaki rats, " Surgical Endoscopy, vol. 29, no. 3, pp. 723-733, 2015.
146. T. Sillakivi, J. Suumann, U. Kirsimgi, and A. Peetsalu, "Plasma levels of gastric biomarkers in patients after bariatric surgery: biomarkers after bariatric surgery, " Hepato-Gastroenterology, vol. 60, no. 128, pp. 2129-2132, 2013.
147. J. R. Shak, J. Roper, G. I. Perez-Perez et al. , "The effect of laparoscopic gastric banding surgery on plasma levels of appetitecontrol, insulinotropic, and digestive hormones, " Obesity Surgery, vol. 18, no. 9, pp. 1089-1096, 2008.
148. N. Basso, D. Capoccia, M. Rizzello et al. , "First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: The gastric hypothesis, " Surgical Endoscopy, vol. 25, no. 11, pp. 3540-3550, 2011.
149. N. G. de laTorre, M. A. Rubio, E. Bordi et al. , "Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin, " The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 11, pp. 4276-4281, 2008.
150. B. Woelnerhanssen, R. Peterli, R. E. Steinert, T. Peters, Y. Borbly, and C. Beglinger, "Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial, " Surgery for Obesity and Related Diseases, vol. 7, no. 5, pp. 561-568, 2011.
151. G. Frhbeck, A. Diez-Caballero, J. Gmez-Ambrosi et al. , "Disruption of the leptin-insulin relationship in obese men 24 hours after laparoscopic adjustable silicone gastric banding, " Obesity Surgery, vol. 12, no. 3, pp. 366-371, 2002.
152. P. Maruna, R. Grlich, M. Fried, R. Frasko, I. Chachkhiani, and M. Haluzik, "Leptin as an acute phase reactant after nonadjustable laparoscopic gastric banding, " Obesity Surgery, vol. 11, no. 5, pp. 609-614, 2001.
153. M. A. Trakhtenbroit, J. G. Leichman, M. F. Algahim et al. , "Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery, " The American Journal of Medicine, vol. 122, no. 5, pp. 435-442, 2009.
154. F. Carrasco, K. Basfi-Fer, P. Rojas et al. , "Changes in bone mineral density after sleeve Gastrectomy or gastric bypass: relationships with variations in vitaminD, ghrelin, and adiponectin levels, " Obesity Surgery, vol. 24, no. 6, pp. 877-884, 2014.
155. C. C. Coughlin, B. N. Finck, J. C. Eagon et al. , "Effect of marked weight loss on adiponectin gene expression and plasma concentrations, " Obesity, vol. 15, no. 3, pp. 640-645, 2007.
156. M. M. Swarbrick, I. T. Austrheim-Smith, K. L. Stanhope et al. , "Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery, " Diabetologia, vol. 49, no. 11, pp. 2552-2558, 2006.
157. C. Shrestha, H. He, Y. Liu, S. Zhu, J. Xiong, andZ. Mo, "Changes in adipokines following laparoscopic Roux-en-Y gastric bypass surgery in Chinese individuals with type 2 diabetesmellitus and BMI of 22-30 kgm2, " International Journal of Endocrinology, vol. 2013, Article ID 240971, 6 pages, 2013.
158. L. M. Umeda, A. Z. Pereira, G. Carneiro, C. H. Arasaki, and M. T. Zanella, "Postprandial adiponectin levels are associated with improvements in postprandial triglycerides after Roux-en-Y gastric bypass in type 2 diabetic patients, " Metabolic Syndrome and Related Disorders, vol. 11, no. 5, pp. 343-348, 2013.
159. J. V. Li, H. Ashrafian, M. Bueter et al. , "Metabolic surgery profoundly influences gut microbial-hostmetabolic cross-talk, " Gut, vol. 60, no. 9, pp. 1214-1223, 2011.
160. H. Zhang, J. K. DiBaise, A. Zuccolo et al. , "Human gut microbiota in obesity and after gastric bypass, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 7, pp. 2365-2370, 2009.
161. J. V. Li, R. Reshat, Q. Wu et al. , "Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents, " Frontiers in Microbiology, vol. 2, article 183, 2011.
162. A. P. Liou, M. Paziuk, J.-M. Luevano Jr. , S. Machineni, P. J. Turnbaugh, and L. M. Kaplan, "Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity, " Science TranslationalMedicine, vol. 5, no. 178, Article ID 178ra41, 2013.
163. J. Graessler, Y. Qin, H. Zhong et al. , "Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters, " The Pharmacogenomics Journal, vol. 13, no. 6, pp. 514-522, 2013.